Effect of direct thrombin inhibitors on laboratory measurement of fibrinogen: Potential for errors in clinical decision-making.

Jennings, Ian; Lester, Will; Gray, Elaine; Reilly-Stitt, Chris; Gomez, Keith; Williams, Stella; Kitchen, Steve; Walker, Isobel

Jennings, Ian; Lester, Will; Gray, Elaine; Reilly-Stitt, Chris; Gomez, Keith; Williams, Stella; Kitchen, Steve; Walker, Isobel.

Afiliação

Jennings I; UK NEQAS (Blood Coagulation), Sheffield, UK.
Lester W; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Gray E; South Mimms Laboratories, Medicines and Healthcare Products Regulatory Agency, Potters Bar, UK.
Reilly-Stitt C; UK NEQAS (Blood Coagulation), Sheffield, UK.
Gomez K; Haemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, UK.
Williams S; South Mimms Laboratories, Medicines and Healthcare Products Regulatory Agency, Potters Bar, UK.
Kitchen S; UK NEQAS (Blood Coagulation), Sheffield, UK.
Walker I; UK NEQAS (Blood Coagulation), Sheffield, UK.

Int J Lab Hematol ; 45(4): 599-602, 2023 08.

Article em En | MEDLINE | ID: mdl-36793181

Assuntos

Antitrombinas; Hemostáticos; Humanos; Fibrinogênio; Trombina; Tomada de Decisão Clínica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemostáticos / Antitrombinas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google